Manufacturer
L.B.S. LABS LTD PART
Contents
Ceftriaxone Na
Indication
Treatment of infections caused by pathogens sensitive to ceftriaxone: Respiratory tract infections, pneumonia, ear, nose and throat infection; infections of the bones, joints, soft tissue, skin and of wounds; abdominal infections (peritonitis, infections of biliary and gastrointestinal tract); renal and urinary tract infections; genital infection including gonorrhea; infection in patients with impaired defense mechanisms; perioperative prophylaxis of infection; sepsis; meningitis.
Instruction
Administer via IV/IM injection.
Drug interaction
May increase anticoagulant effect of vit K antagonists (e.g. warfarin). May increase nephrotoxicity of aminoglycosides. May diminish therapeutic effect of BCG, typhoid vaccine, Na picosulfate. Potentially Fatal: Admin with Ca-containing IV solution may cause precipitation of a crystalline material in the lungs and kidneys.
L.B.S. LABS LTD PART
Contents
Ceftriaxone Na
Indication
Treatment of infections caused by pathogens sensitive to ceftriaxone: Respiratory tract infections, pneumonia, ear, nose and throat infection; infections of the bones, joints, soft tissue, skin and of wounds; abdominal infections (peritonitis, infections of biliary and gastrointestinal tract); renal and urinary tract infections; genital infection including gonorrhea; infection in patients with impaired defense mechanisms; perioperative prophylaxis of infection; sepsis; meningitis.
Instruction
Administer via IV/IM injection.
Drug interaction
May increase anticoagulant effect of vit K antagonists (e.g. warfarin). May increase nephrotoxicity of aminoglycosides. May diminish therapeutic effect of BCG, typhoid vaccine, Na picosulfate. Potentially Fatal: Admin with Ca-containing IV solution may cause precipitation of a crystalline material in the lungs and kidneys.
Inquiry - Trixone Injection 250mg